However, the liver grafts from HBc-Ab positive donors are currently main sources of de novo hepatitis due to HBV cross infection after LDLT; therefore, HBs-Ag negative recipients should receive appropriate prophylaxis [2, 11–13]. This evidence concerns the gene KRT88P and hepatitis A virus infection.